Nebula Genomics, a biotechnology and healthcare startup, was founded in 2016 with a focus on leveraging blockchain technology to enable secure and private genomic data sharing. The company recently received a significant $4.30M Series A investment on 10 October 2018. The investment was led by a consortium of high-profile investors including XFund, Arch Venture Partners, Fenbushi Capital, F-Prime Capital, Mayfield, Mirae Asset, Windham Venture Partners, Hemi Ventures, Hikma Ventures, and Great Point Partners.
General Information
BounceWatch is an independent company data service, not affiliated with Nebula Genomics. To contact Nebula Genomics, visit nebula.org.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Nebula Genomics compare?
A PDF of Nebula Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Nebula Genomics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Nebula Genomics
Funding Rounds & Investors (2)
View AllNebula Genomics Alternatives & Competitors
View All AlternativesFuture of Healthcare, Healthcare of Future
Developing Cell Therapies for Degenerative Disease.
Making tissue therapeutics possible to defeat serious disease
FAQ About Nebula Genomics
Source: BounceWatch company record for Nebula Genomics, https://bouncewatch.com/company/nebula-genomics, updated 30 December 2024. When citing, please name BounceWatch and link this page.